Passage Bio (PASG) Competitors $5.59 -0.37 (-6.19%) Closing price 03:59 PM EasternExtended Trading$5.62 +0.02 (+0.43%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PASG vs. ETNB, SDGR, JANX, VERA, TVTX, EWTX, EVO, BHVN, MESO, and ANIPShould you be buying Passage Bio stock or one of its competitors? The main competitors of Passage Bio include 89BIO (ETNB), Schrodinger (SDGR), Janux Therapeutics (JANX), Vera Therapeutics (VERA), Travere Therapeutics (TVTX), Edgewise Therapeutics (EWTX), Evotec (EVO), Biohaven (BHVN), Mesoblast (MESO), and ANI Pharmaceuticals (ANIP). These companies are all part of the "pharmaceutical products" industry. Passage Bio vs. Its Competitors 89BIO Schrodinger Janux Therapeutics Vera Therapeutics Travere Therapeutics Edgewise Therapeutics Evotec Biohaven Mesoblast ANI Pharmaceuticals 89BIO (NASDAQ:ETNB) and Passage Bio (NASDAQ:PASG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends. Does the media favor ETNB or PASG? In the previous week, 89BIO had 2 more articles in the media than Passage Bio. MarketBeat recorded 6 mentions for 89BIO and 4 mentions for Passage Bio. 89BIO's average media sentiment score of 0.75 beat Passage Bio's score of -0.03 indicating that 89BIO is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 89BIO 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Passage Bio 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of ETNB or PASG? 53.5% of Passage Bio shares are held by institutional investors. 2.8% of 89BIO shares are held by company insiders. Comparatively, 4.3% of Passage Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable valuation and earnings, ETNB or PASG? 89BIO is trading at a lower price-to-earnings ratio than Passage Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio89BION/AN/A-$367.08M-$3.38-3.14Passage BioN/AN/A-$64.77M-$20.40-0.27 Which has more risk & volatility, ETNB or PASG? 89BIO has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Passage Bio has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500. Do analysts recommend ETNB or PASG? 89BIO presently has a consensus price target of $26.43, suggesting a potential upside of 148.81%. Passage Bio has a consensus price target of $150.00, suggesting a potential upside of 2,582.88%. Given Passage Bio's higher possible upside, analysts clearly believe Passage Bio is more favorable than 89BIO.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 89BIO 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.00Passage Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ETNB or PASG more profitable? 89BIO's return on equity of -81.44% beat Passage Bio's return on equity.Company Net Margins Return on Equity Return on Assets 89BION/A -81.44% -70.17% Passage Bio N/A -93.59%-59.65% SummaryPassage Bio beats 89BIO on 7 of the 12 factors compared between the two stocks. Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PASG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PASG vs. The Competition Export to ExcelMetricPassage BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.44M$2.93B$5.57B$9.32BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-0.2720.5028.6419.75Price / SalesN/A267.15432.34182.50Price / CashN/A43.1536.0257.96Price / Book0.287.768.235.67Net Income-$64.77M-$55.11M$3.24B$257.98M7 Day Performance-36.61%1.03%0.05%0.56%1 Month Performance-30.60%8.54%5.65%8.88%1 Year Performance-70.61%-2.26%26.57%14.24% Passage Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PASGPassage Bio2.5202 of 5 stars$5.59-6.2%$150.00+2,582.9%-67.7%$17.44MN/A-0.27130Stock SplitGap DownHigh Trading VolumeETNB89BIO1.8202 of 5 stars$11.12+1.1%$26.43+137.7%+16.8%$1.62BN/A-3.2940SDGRSchrodinger1.7947 of 5 stars$21.14+0.6%$32.75+54.9%-10.2%$1.55B$207.54M-8.04790Analyst ForecastJANXJanux Therapeutics2.6808 of 5 stars$26.18+4.1%$91.89+251.0%-40.7%$1.55B$9.34M-19.2530News CoverageVERAVera Therapeutics4.226 of 5 stars$23.78-0.2%$65.00+173.3%-36.9%$1.52BN/A-7.9340Positive NewsTVTXTravere Therapeutics3.7944 of 5 stars$16.91+2.7%$32.14+90.1%+67.0%$1.50B$233.18M-6.02460Analyst RevisionEWTXEdgewise Therapeutics1.4581 of 5 stars$13.93+0.7%$40.00+187.2%-41.5%$1.47BN/A-8.9960EVOEvotec1.9816 of 5 stars$4.12+1.2%$5.93+44.0%-13.8%$1.46B$862.40M0.004,827BHVNBiohaven3.3508 of 5 stars$14.18+1.8%$58.46+312.2%-65.5%$1.45BN/A-1.52239Trending NewsMESOMesoblast2.1929 of 5 stars$11.17+0.5%$18.00+61.1%+43.3%$1.43B$5.90M0.0080Positive NewsGap UpANIPANI Pharmaceuticals3.7316 of 5 stars$65.19+0.4%$78.88+21.0%+1.2%$1.41B$674.07M-51.33600News CoverageAnalyst Revision Related Companies and Tools Related Companies ETNB Alternatives SDGR Alternatives JANX Alternatives VERA Alternatives TVTX Alternatives EWTX Alternatives EVO Alternatives BHVN Alternatives MESO Alternatives ANIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PASG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PASG Stock Alerts